| mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0071 |
0.8 |
| mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0073 |
0.8 |
| mRNA |
FSC231 |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.8 |
| mRNA |
SB52334 |
GDSC1000 |
pan-cancer |
AAC |
-0.0065 |
0.8 |
| mRNA |
VNLG/124 |
GDSC1000 |
pan-cancer |
AAC |
-0.0063 |
0.8 |
| mRNA |
CUDC-101 |
GDSC1000 |
pan-cancer |
AAC |
0.006 |
0.8 |
| mRNA |
PD173074 |
GDSC1000 |
pan-cancer |
AAC |
-0.0067 |
0.9 |
| mRNA |
Crizotinib |
gCSI |
pan-cancer |
AAC |
0.011 |
0.9 |
| mRNA |
FQI-1 |
CTRPv2 |
pan-cancer |
AAC |
0.0088 |
0.9 |
| mRNA |
17-AAG |
GDSC1000 |
pan-cancer |
AAC |
-0.0059 |
0.9 |